跳转至内容
Merck
CN
所有图片(1)

主要文件

SML1900

Sigma-Aldrich

Sobetirome(甲状腺激素类药物)

≥98% (HPLC)

别名:

2- [4-[[4-羟基-3-(1-甲基乙基)苯基]甲基] -3,5-二甲基苯氧基]乙酸, 3,5-二甲基-4-(4′-羟基-3′-异丙基苄基)苯氧乙酸, GC 1, GC-1

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C20H24O4
分子量:
328.40
UNSPSC代码:
51111800
NACRES:
NA.77

质量水平

方案

≥98% (HPLC)

表单

powder

颜色

white to beige

溶解性

DMSO: 10 mg/mL, clear

储存温度

−20°C

SMILES字符串

O(CC(=O)O)c1cc(c(c(c1)C)Cc2cc(c(cc2)O)C(C)C)C

InChI

1S/C20H24O4/c1-12(2)17-9-15(5-6-19(17)21)10-18-13(3)7-16(8-14(18)4)24-11-20(22)23/h5-9,12,21H,10-11H2,1-4H3,(H,22,23)

InChI key

QNAZTOHXCZPOSA-UHFFFAOYSA-N

生化/生理作用

Sobetirome也称为2-(4-(4-苄氧基)-3-异丙基苄基)-3,5-二甲基苯氧基)乙酸/GC-1。它在生理pH下具有一个内环和带负电荷的羧酸盐基团。Sobetirome被认为可以降低人体的胆固醇水平。
Sobetirome是甲状腺激素受体(TR) β 和 TRα 的口服活性、强效激动剂,表现出选择性的组织作用。
Sobetirome是甲状腺激素受体(TR) β 和 TRα 的口服活性、强效激动剂,表现出选择性的组织作用。Sobetirome对心脏、骨骼和骨骼肌的无甲状腺毒性作用。

储存分类代码

11 - Combustible Solids

WGK

WGK 3


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

K Kannisto et al.
Atherosclerosis, 237(2), 544-554 (2014-12-03)
Thyroid hormone reduces plasma cholesterol and increases expression of low-density lipoprotein receptor (LDL-R) in liver, an effect mediated by thyroid receptor β (TRβ). The selective TRβ modulator GC-1 also enhances several steps in reverse cholesterol transport and can decrease serum
Jan Lammel Lindemann et al.
Expert opinion on therapeutic targets, 20(2), 145-149 (2015-11-14)
Sobetirome binds selectively to the main hepatic form of thyroid hormone (TH) receptor, TRβ1, compared to TRα1, which is principally responsible for thyrotoxic effects on heart, muscle and bone. Sobetirome also preferentially accumulates in liver. It was originally envisaged that
Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration.
Ferrara SJ, et al.
Bioorganic & Medicinal Chemistry, 25(10), 2743-2753 (2017)
Andrew T Placzek et al.
Bioorganic & medicinal chemistry, 24(22), 5842-5854 (2016-10-26)
There is currently great interest in developing drugs that stimulate myelin repair for use in demyelinating diseases such as multiple sclerosis. Thyroid hormone plays a key role in stimulating myelination during development and also controls the expression of important genes
Sobetirome prodrug esters with enhanced blood?brain barrier permeability.
Placzek AT, et al.
Bioorganic & Medicinal Chemistry, 24(22), 5842-5854 (2016)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门